Skip to main content

Table 3 Patient characteristics per chart audit

From: Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit

Variable

Statistic

N = 1336

Setting

 Office

802 (60%)

 (US only) Outpatient Community Health Clinic

75 (6%)

 (France only) Centre Medical Psychologique

53 (4%)

 Hospital Outpatient Clinic

351 (26%)

 Telemedicine

12 (1%)

 Patient’s Home

23 (2%)

 Day Clinic

19 (1%)

 Other

1 (< 1%)

Length of MDD diagnosis

 < 1 month

88 (7%)

 1–3 months

174 (13%)

 4–6 months

180 (14%)

 7–9 months

65 (5%)

 10–12 months

211 (16%)

 2–5 years

370 (28%)

 6 + years

248 (19%)

Current treatment

 SSRI

800 (60%)

 SNRI

320 (24%)

 MAOI

7 (< 1%)

 TCA

49 (4%)

 Other antidepressant

295 (22%)

 Anxiolytic

239 (18%)

 Antipsychotic

243 (18%)

 Hypnotic

76 (6%)

 Other treatment for depression

69 (5%)

Mean current ADT duration by treatment class (weeks)

 SSRI

45.4

 SNRI

48.7

 MAOI

22.0

 TCA

106.8

 Other antidepressant

38.9

Number of current classes of prescription treatments for depression (this episode); n (%)

 0

6 (< 1%)

 1

755 (57%)

 2

397 (30%)

 3

145 (11%)

 4

28 (2%)

 5 +

5 (< 1%)

 Mean number

1.6

Level of functioning (mean SDS scores)

 SDS Mean score

5.1

 Work domain

6.0

 Social domain

4.7

 Home domain

4.5

PHQ-9 score (mean)

6.2

Clinical global impression of change in depression since onset of episode to current visit

 Very much worse

5 (< 1%)

 Much worse

63 (5%)

 Minimally worse

113 (9%)

 No change

248 (19%)

 Minimally improved

413 (31%)

 Much improved

400 (30%)

 Very much improved

94 (7%)